- Home
- FBRX vs SHOE Comparison
FBRX vs SHOE Comparison
Compare FBRX & SHOE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$18.17
N/A
Current Price
$15.70
Company Overview
Basic Information| Metric | FBRX | SHOE |
|---|---|---|
| Founded | N/A | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Clothing/Shoe/Accessory Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 487.2M | 457.5M |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | FBRX | SHOE |
|---|---|---|
| Price | $18.17 | $15.70 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $67.00 | N/A |
| AVG Volume (30 Days) | ★ 240.3K | N/A |
| Earning Date | 05-14-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 61.30 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $36,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $9.12 | N/A |
| 52 Week High | $35.80 | N/A |
Technical Indicators
Market Signals| Indicator | FBRX | SHOE |
|---|---|---|
| Relative Strength Index (RSI) | 41.39 | N/A |
| Support Level | $17.33 | N/A |
| Resistance Level | $22.84 | N/A |
| Average True Range (ATR) | 1.29 | 0.00 |
| MACD | 0.39 | 0.00 |
| Stochastic Oscillator | 63.90 | 0.00 |
Price Performance
Historical Comparison FBRX
SHOE
About FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a clinical-stage biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary anti-CD122 monoclonal antibody therapeutic candidate with potentially broad autoimmune and autoimmune-related indications. The Company is also advancing clinical development of FB102 in patient-based trials for non-segmental vitiligo and alopecia areata.